Extralehdet Extralehdet
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
Latest posts by Toimitus (see all)
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Lisätietoja Toimitus
Katso myös
Little Foot hominin fossil may be new species of human ancestor
Australian researchers think the skeleton found in South Africa is not the same species as …